Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Allogeneic Stem Cell Transplantation in a Large Urban Cohort of North-American Adult T-Cell Leukemia/Lymphoma

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-140812

Published: 2020

Journal Articles

Conventional Chemotherapy Treatment Induces Unique Patterns of Clonal Evolution in a North American Adult T Cell Leukemia/Lymphoma Cohort

Blood (2019) 134 (Supplement_1): 1551.

https://doi.org/10.1182/blood-2019-131107

Published: 2019

Journal Articles

Risk Stratification and Transfusion Dependence Are Independent Risk Factors for Cardiovascular Disease (CVD) in Myelodysplastic Syndrome (MDS)

Diego Adrianzen Herrera, MD, Kith Pradhan, PhD, Rosebella Snyder, MD, Siddharth Karanth, MBBS, MPH, DrPH, Murali Janakiram, MD MS, Ioannis Mantzaris, MD MS, Santosh Murthy, MD MPH, Amit Verma, MBBS, Aditi Shastri, MD

Blood (2019) 134 (Supplement_1): 336.

https://doi.org/10.1182/blood-2019-123317

Published: 2019

Journal Articles

Myelodysplastic Syndromes (MDS) Are an Independent Risk Factor for an Earlier Onset of Myocardial Infarction and Increased Mortality from Cardiovascular Disease (CVD)

Blood (2018) 132 (Supplement 1): 3539.

https://doi.org/10.1182/blood-2018-99-115613

Published: 2018

Journal Articles

Obesity Is Associated with Younger Age at Presentation and More Severe Cytopenias in Myelodysplastic Syndromes

Santiago Thibaud, MD, Diego Adrianzen Herrera, MD, Rosebella Snyder, Justin D. Kaner, MD, Ioannis Mantzaris, MD, Swati Goel, MD, Amit Verma, MD, Aditi Shastri, MD

Blood (2017) 130 (Supplement 1): 5312.

https://doi.org/10.1182/blood.V130.Suppl_1.5312.5312

Published: 2017

Journal Articles

Autologous Transplantation Is Associated with Better Outcomes Compared to Chemotherapy Alone in a Minority-Rich Non-High-Risk Acute Myeloid Leukemia Cohort

Diego Adrianzen Herrera, MD, Nilupa Gaspe Mudiyanselage, MD, Pramod Gaudel, MD, Anjali Budhathoki, MD, Karine Darbinyan, MD, Aditi Shastri, MD, Murali Janakiram, MD, Adam F. Binder, MD, Noah Kornblum, MD, Olga Derman, Kira Gritsman, MD PhD, Ulrich G. Steidl, MDPhD, Amit Verma, MD, Ira Braunschweig, MD, Ioannis Mantzaris, MD

Blood (2017) 130 (Supplement 1): 3293.

https://doi.org/10.1182/blood.V130.Suppl_1.3293.3293

Published: 2017

Journal Articles

Comparable Survival and Incidence of Toxicity for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

Gunjan L. Shah, MDMS, Michael Scordo, MD, Satyajit Kosuri, MD, Diego Adrianzen Herrera, MD, Molly A. Maloy, MS, Jimmy Nieves, RN, Sean Devlin, PhD, Taylor Borrill, CCRP, Scott T. Avecilla, MD PhD, Richard C. Meagher, PhD, Richard J. O'Reilly, MD, Guenther Koehne, MD PhD, Brian C. Shaffer, MD, Miguel-Angel Perales, MD, Boglarka Gyurkocza, MD, Hugo R. Castro-Malaspina, MD, Sergio A. Giralt, MD, Roni Tamari, MD

Blood (2016) 128 (22): 1236.

https://doi.org/10.1182/blood.V128.22.1236.1236

Published: 2016

Journal Articles

A Comprehensive Analysis of Late Toxicities and Associated Risk Factors in Long-Term Survivors of Myeloablative Conditioned Allogeneic Hematopoietic Cell Transplantation Using Ex-Vivo CD34+ Selection-Based Graft-Versus-Host Disease Prophylaxis

Michael Scordo, MD, Gunjan L. Shah, MDMS, Satyajit Kosuri, MD, Diego Adrianzen Herrera, MD, Sean Devlin, PhD, Molly A. Maloy, MS, Jimmy Nieves, RN, Taylor Borrill, CCRP, Scott T. Avecilla, MD PhD, Richard C. Meagher, PhD, Richard J. O'Reilly, MD, Guenther Koehne, MD PhD, Boglarka Gyurkocza, MD, Hugo Castro-Malaspina, MD, Roni Tamari, MD, Miguel Perales, MD, Sergio A. Giralt, MD, Brian C. Shaffer, MD

Blood (2016) 128 (22): 4621.

https://doi.org/10.1182/blood.V128.22.4621.4621

Published: 2016

Journal Articles

An Analysis of Early Toxicities, Associated Risk Factors and Survival during the First Year in Adults Undergoing Ex-Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

Satyajit Kosuri, MD, Diego Adrianzen Herrera, MD, Michael Scordo, MD, Gunjan Shah, MD M.S., Molly A. Maloy, MS, Sean Devlin, PhD, Jimmy Nieves, RN, Taylor Borrill, CCRP, Scott T. Avecilla, MD PhD, Richard C. Meagher, PhD, Richard J. O'Reilly, MD, Guenther Koehne, MD PhD, Brian C. Shaffer, MD, Boglarka Gyurkocza, MD, Hugo R. Castro-Malaspina, MD, Roni Tamari, MD, Sergio A. Giralt, MD, Miguel Perales, MD

Blood (2016) 128 (22): 2194.

https://doi.org/10.1182/blood.V128.22.2194.2194

Published: 2016

NARROW

Allogeneic Stem Cell Transplantation in a Large Urban Cohort of North-American Adult T-Cell Leukemia/Lymphoma

Conventional Chemotherapy Treatment Induces Unique Patterns of Clonal Evolution in a North American Adult T Cell Leukemia/Lymphoma Cohort

Risk Stratification and Transfusion Dependence Are Independent Risk Factors for Cardiovascular Disease (CVD) in Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes (MDS) Are an Independent Risk Factor for an Earlier Onset of Myocardial Infarction and Increased Mortality from Cardiovascular Disease (CVD)

Obesity Is Associated with Younger Age at Presentation and More Severe Cytopenias in Myelodysplastic Syndromes

Autologous Transplantation Is Associated with Better Outcomes Compared to Chemotherapy Alone in a Minority-Rich Non-High-Risk Acute Myeloid Leukemia Cohort

Comparable Survival and Incidence of Toxicity for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

A Comprehensive Analysis of Late Toxicities and Associated Risk Factors in Long-Term Survivors of Myeloablative Conditioned Allogeneic Hematopoietic Cell Transplantation Using Ex-Vivo CD34+ Selection-Based Graft-Versus-Host Disease Prophylaxis

An Analysis of Early Toxicities, Associated Risk Factors and Survival during the First Year in Adults Undergoing Ex-Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only